The Effects of Helicobacter pylori Eradication on Proteinuria in Patients with Primary Glomerulonephritis.
Background. Membranous nephropathy (MN) is a common cause of nephrotic syndrome. In most cases it is idiopathic, while it may also be secondary to many diseases. In this study, prevalence of H. pylori infection and the effects of H. pylori eradication on proteinuria levels were investigated. Methods. Thirty five patients with MN (19 male), 12 patients with IgA nephropathy (4 male) and 12 patients with focal segmental glomerulosclerosis (FSGS) (8 male) were studied. The presence of H. pylori antigen was investigated in renal tissues obtained by biopsy, and the effects of H. pylori eradication on proteinuria levels were investigated. Results. Immunohistochemistry with H. pylori antigen revealed no positive staining in the glomeruli of all patients. 19 patients (54%) with MN, 10 (83%) with IgA nephropathy and 4 (33%) with FSGS were positive for H. pylori stool antigen test (P = 0.045). Patients with H. pylori infection were administered eradication therapy (lansoprazole, 30 mg twice daily, plus amoxicillin, 0.75 g twice daily, plus clarithromycin, 250 mg twice daily, for 14 days). Before the eradication therapy the mean proteinuria of patients with MN, IgA nephropathy and FSGS were 2.42 ± 3.24 g/day, 2.12 ± 1.63 g/day and 1.80 ± 1.32 g/day, respectively. Three months after eradication, baseline proteinuria levels of patients with MN significantly decreased to 1.26 ± 1.73 g/day (P = 0.031). In all three groups there were no significant differences with regard to serum creatinine, albumin and C-reactive protein levels before and after eradication therapy. Conclusions. The eradication of H. pylori infection may be effective to reduce proteinuria in patients with MN, while spontaneous remission of MN could not be excluded in this patient cohort. This trial is registered with NCT00983034.
Division of Pediatric Infectious Diseases, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Bahar
B
Caliskan
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Millet Caddesi, Capa, 34093 Istanbul, Turkey.
Halil
0000-0003-2526-3483
H
Yazici
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Millet Caddesi, Capa, 34093 Istanbul, Turkey.
Yasar
Y
Caliskan
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Yasemin
Y
Ozluk
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Mine
M
Gulluoglu
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Isin
I
Kilicaslan
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Millet Caddesi, Capa, 34093 Istanbul, Turkey.
Aydin
A
Turkmen
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Millet Caddesi, Capa, 34093 Istanbul, Turkey.
Mehmet Sukru
MS
Sever